LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Home・Stock List・Medtronic PLC

Search

Medtronic PLC

Closed

SectorHealthcare

76.02 -2.5

Overview

Share price change

24h

Current

Min

75.91

Max

78.13

Key metrics
By Trading Economics
Income	-231M 1.1B
Sales	57M 9B
P/E Sector Avg	22.308 49.8
EPS	1.36
Dividend yield	3.54
Profit margin	12.675
Employees	95,000
EBITDA	124M 2.5B

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+35.43% upside

Dividends
By Dow Jones
Dividend yield Sector Avg	3.54% 2.25%
Next Earnings	3 Jun 2026
Next Dividend date	10 Jul 2026
Next Ex Dividend date	26 Jun 2026

Market Stats
By TradingEconomics
Market Cap	-27B 101B
Previous open	78.52
Previous close	76.02

News Sentiment

By Acuity

22%

78%

41 / 347 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bearish Evidence

83.26 / 84.875 Support & Resistance

Medtronic PLC Chart

Past performance is not a reliable indicator of future results.

Related News

10 Mar 2026, 11:19 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Buy Scientia Vascular in $550 Million Deal

17 Feb 2026, 12:43 UTC

Earnings

Medtronic 3Q Profit Falls Despite Higher Revenue

3 Feb 2026, 13:53 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Acquire CathWorks in Deal Valued Up to $585 Million

22 Apr 2026, 11:27 UTC

Earnings

Intuitive Surgical Earnings Show Big Beats Don't Always Spark Stock Rallies -- Barrons.com

20 Apr 2026, 11:50 UTC

Acquisitions, Mergers, Takeovers

Medtronic Completes Acquisition Of CathWorks, Expanding Its Leadership In Transforming Care For Patients With Cardiovascular Disease >MDT

24 Mar 2026, 20:59 UTC

Earnings

Medtronic PLC Cuts FY26 View To Adj EPS $5.50-Adj EPS $5.54 >MDT

10 Mar 2026, 10:46 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Deal Complements Neurovascular Portfolio >MDT

10 Mar 2026, 10:46 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Deal Includes Potential Undisclosed Earn-Out, Milestone Payments >MDT

10 Mar 2026, 10:45 UTC

Acquisitions, Mergers, Takeovers

Medtronic: Scientia Vascular Acquisition Valued at $550 Million >MDT

10 Mar 2026, 10:45 UTC

Acquisitions, Mergers, Takeovers

Medtronic to Acquire Scientia Vascular >MDT

17 Feb 2026, 21:21 UTC

Earnings

These Stocks Are Today's Movers: Paramount, Masimo, Medtronic, Kyndryl, eToro, Genuine Parts, Southwest, and More -- Barrons.com

17 Feb 2026, 18:11 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 Feb 2026, 14:48 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 Feb 2026, 13:00 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 Feb 2026, 12:05 UTC

Earnings

Medtronic Posts Better-Than-Expected Earnings. Here's Why the Stock Is Falling. -- Barrons.com

17 Feb 2026, 11:47 UTC

Earnings

Medtronic Sees 2026 EPS up 4.5%, Excluding Potential Impact From Tariffs >MDT

17 Feb 2026, 11:47 UTC

Earnings

Medtronic Still Sees FY26 Organic Revenue Up About 5.5% >MDT

17 Feb 2026, 11:46 UTC

Earnings

Medtronic FY26 View Includes Potential Impact From Tariffs of About $185M >MDT

17 Feb 2026, 11:46 UTC

Earnings

Medtronic Backs FY26 View of Adj EPS $5.62-Adj EPS $5.66 >MDT

17 Feb 2026, 11:46 UTC

Earnings

Medtronic Reiterates FY26 Organic Rev Growth, EPS Guidance >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Adj EPS $1.36 >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Neuroscience Portfolio Rev $2.56B >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Organic Revenue Up 6.0% >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Sales $9.02B >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Diabetes Rev $796M >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Cardiovascular Portfolio Rev $3.46B >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Medical Surgical Portfolio Rev $2.17B >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q Net $1.14B >MDT

17 Feb 2026, 11:45 UTC

Earnings

Medtronic 3Q EPS 89c >MDT

17 Feb 2026, 09:53 UTC

Hot Stocks

Stocks to Watch Tuesday: Norwegian, Hyatt, Zim, Medtronic -- WSJ

Peer Comparison

Price change

Medtronic PLC Forecast

Price Target

By TipRanks

35.43% upside

12 Months Forecast

Average 105.58 USD 35.43%

High 120 USD

Low 86 USD

Based on 21 Wall Street analysts offering 12 month price targets forMedtronic PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

21 ratings

12

Buy

9

Hold

0

Sell

Based on 21 analysts giving stock ratings to Medtronic PLC - Dist in the past 3 months.

Technical Score

By Trading Central

83.26 / 84.875Support & Resistance

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentiment

By Acuity

41 / 347 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.

Other stocks from the sector

LLY

Eli Lilly and Co.

947.62

JNJ

Johnson and Johnson

221.12

ABBV

AbbVie Inc

201.14

UNH

UnitedHealth Group Inc

379.44

AZN

AstraZeneca PLC

182.32

Live chat